Health in Belarus 1,053 indicators covering health for Belarus. IndicatorLatest Year10-yr change Rank Death rates cocaine overdoses by age 0 2021 — 1st Deaths drug use disorders by sex 47.28 2021 down 51.1% 42nd Deaths cocaine overdoses by sex 0.81 2021 down 59.7% 84th Deaths amphetamine overdoses by sex 1.28 2021 down 67.6% 52nd Deaths opioid overdoses by sex 40.62 2021 down 49.0% 37th Deaths from substance disorders who 2,426 2021 down 26.7% 15th Death rates substance disorders who 26.22 2021 down 24.9% 2nd Death rates alcohol drug overdoses by age who 0 2021 — 15th Deaths alcohol drugs by sex who 759.67 2021 down 18.7% 13th Dengue fever deaths 0 2021 — 103rd Death rate from cardiovascular disease age standardized ghe 397.31 2021 down 20.8% 23rd Deaths from cardiovascular disease type 171.96 2021 down 47.6% 77th Death rate from rheumatic heart disease who ghe age standardized 1.1 2021 down 54.2% 106th Death rate from hypertensive heart disease who ghe age standardized 0.9377 2021 down 59.3% 191st Death rate from ischaemic heart disease who ghe age standardized 290.76 2021 down 18.5% 6th Deaths from cardiovascular diseases by region 72,406 2021 down 12.8% 39th Total disease burden who 4.27 million 2021 down 7.0% 85th Burden of disease who 44,614 2021 down 5.8% 45th Rate of disease burden from drug use disorders who 215.26 2021 down 41.7% 30th Respiratory infections death rate age group 16.21 2018 — 59th Respiratory infection death rate who mdb 6.9 2018 — 107th Prevalence of moderate or severe food insecurity in the population 1.1% 2023 — 126th Male female ratio suicides rates 6.62 2021 up 1.3% 9th Number of people notified with new episode of TB in a given year 1,696 2021 down 66.9% 111th Number of people diagnosed with new episode of pulmonary TB who are cl 49 2021 down 98.0% 130th Number of people diagnosed with new episode of pulmonary TB who have e 103 2021 down 73.4% 129th Share of women who are smoking 14.1 2022 down 4.7% 52nd Comparing the share of men and women who are smoking 46.4 2022 down 20.7% 25th Share of men who are smoking 46.4 2022 down 20.7% 25th Adults smoking 2007 2018 30.2 2022 down 17.5% 31st Cases started on MDR-TB treatment 520 2024 down 72.7% 28th Prevalence of severe food insecurity in the population 0.0% 2023 — 121st Share healthy diet unaffordable 0.7 2024 down 78.8% 146th Number of people diagnosed with new episode of pulmonary TB who are ba 1,332 2021 down 38.9% 101st Raised fasting blood glucose (>=7.0 mmol/L) 7.8 2014 up 11.4% 103rd Mean fasting blood glucose (mmol/l) 5.36 2014 up 4.9% 88th Raised fasting blood glucose (>= 7.0 mmol/L) 9.5 2014 up 15.9% 64th Reported number of people requiring interventions against NTDs 0 2024 — 168th Child deaths from streptococcus by disease 1 2015 down 50.0% 126th Births attended by skilled health personnel 99.9% 2024 down 0.1% 20th Percentage of total deaths due to NCDs overall and percentage of total 1.53 2019 down 26.2% 183rd Number of new leprosy cases 0 2021 — 130th Pharmacists 4.66 2024 up 36.3% 72nd Low birth weight prevalence 5.1% 2020 up 2.0% 144th Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 98.0% 2025 down 1.0% 37th Low birth weight number 4.7 2020 down 16.1% 106th Reported rabies deaths 0 2018 down 100.0% 61st Number of current cigarette smokers, estimate 1.43 million 2030 down 20.2% 62nd Concentrations of fine particulate matter 9.66 2023 down 33.8% 149th Death rate road traffic injuries 7.6 2019 down 65.3% 141st New or unknown treatment history cases: Pulmonary, bacteriologically c 1,117 2023 down 50.6% 107th Medical doctors not further defined 2,710 2010 up 3,374.4% 83rd Life satisfaction vs life expectancy 74.43 2023 up 2.4% 128th Estimate of current cigarette smoking prevalence 19.1% 2030 down 17.7% 45th Estimate of current cigarette smoking prevalence (%) 21.2% 2030 down 14.5% 42nd Tb patients tested positive for hiv 128 2021 down 41.0% 78th Number of children aged 6-59 months with anaemia 98.86 2019 up 10.0% 114th Prevalence of anaemia in children aged 6-59 months 17.8% 2019 down 1.7% 153rd Number of deaths attributed to non-communicable diseases, by type of d 18,858 2019 down 7.7% 58th Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 — 132nd ← Previous Page 14 of 18 Next →